NDLI: Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program

Please wait, while we are loading the content...

Year: 2016, Volume: 12

Year: 2015, Volume: 11

Year: 2014, Volume: 11

Year: 2014, Volume: 10

Year: 2013, Volume: 10

Year: 2013, Volume: 9

Year: 2012, Volume: 8

Year: 2011, Volume: 8

Year: 2011, Volume: 7

Year: 2011, Volume: 7, Issue: Unspecified

Exercise electrocardiographic responses and serum cystatin C levels among metabolic syndrome patients without overt diabetes mellitus

Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension

Value of venous color flow duplex scan as initial screening test for geriatric inpatients with clinically suspected pulmonary embolism

Congenital agenesis of internal carotid artery with ipsilateral Horner presenting as focal neurological symptoms

Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta

Pre-eclampsia: pathophysiology, diagnosis, and management

Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study

Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation

Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods

Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospital

Surgery in current therapy for infective endocarditis

The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive

Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders

Benefits of once-daily therapies in the treatment of hypertension

Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview

Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials

Critical review of cancer risk associated with angiotensin receptor blocker therapy

Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications

Stentless aortic valve replacement: an update

Early follow-up results of arteriovenous fistulae created for hemodialysis

Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program

Skeletonized coronary arteries: pathophysiological and clinical aspects of vascular calcification

The causes, consequences, and treatment of left or right heart failure

Comparing patients with spinal cord infarction and cerebral infarction: clinical characteristics, and short-term outcome

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention

Aneurysm of the tibial-saphenous fistula in hemodialysis patient: the results of surgical treatment

Vitamin D status and peripheral arterial disease: evidence so far

Antiplatelet combinations for prevention of atherothrombotic events

Incident prediabetes/diabetes and blood pressure in urban and rural communities in the Democratic Republic of Congo

Office and ambulatory blood pressure control with a fixed-dose combination of candesartan and hydrochlorothiazide in previously uncontrolled hypertensive patients: results of CHILI CU Soon

Coronary sinus intervention for the treatment of refractory angina pectoris

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure

Angiographic estimation of atherosclerotic disease burden in a coronary artery fed by collaterals: a potential pitfall in decision for revascularization

Effects of smoking cessation on central blood pressure and arterial stiffness

ACE up the sleeve – are vascular patients medically optimized?

Superficial venous thrombosis: disease progression and evolving treatment approaches

Doppler study of cerebral arteries in hypercholesterolemia

Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study

Cognitive evolution in hypertensive patients: a six-year follow-up

Reappraisal of role of angiotensin receptor blockers in cardiovascular protection

Effect of alcohol and tobacco use on vascular dementia: a matched case control study

Depression in vascular pathologies: the neurologist’s point of view

Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level

Olmesartan medoxomil for the treatment of hypertension in children and adolescents

Arterial function of carotid and brachial arteries in postmenopausal vegetarians

The occurrence of left ventricular hypertrophy in normotensive individuals in a community setting in North-East Trinidad

Differential clinical profile of candesartan compared to other angiotensin receptor blockers

Validation of four automatic devices for self-measurement of blood pressure according to the international protocol of the European Society of Hypertension

Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials

Novel drug-eluting stents in the treatment of de novo coronary lesions

Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production

The value of blood D-dimer test in the diagnosis of walk-in patients with venous thromboembolism

Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome – a comprehensive cancer center experience

Relevance of tumor angiogenesis patterns as a diagnostic value and prognostic indicator in oral precancer and cancer

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil

Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention

Relating patenting and peer-review publications: an extended perspective on the vascular health and risk management literature

Racial differences in the responses to shear stress in human umbilical vein endothelial cells

Prevalence of significant carotid artery stenosis in Iranian patients with peripheral arterial disease

Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease

The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation

Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting

Retrograde rotational thrombectomy with the Rotarex® catheter system: treatment option for an acute thrombotic occlusion of a subclavian artery

Endothelial function in a cardiovascular risk population with borderline ankle–brachial index

Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk

Risk factor investigation for cardiovascular health through WHO STEPS approach in Ardabil, Iran

Hemorrhagic infarction at 33 days after birth in a healthy full-term neonate

Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium

Renal artery stenosis in kidney transplants: assessment of the risk factors

Olmesartan/amlodipine: a review of its use in the management of hypertension

Troponin elevation in conditions other than acute coronary syndromes

Central aortic blood pressure, augmentation index, and reflected wave transit time: reproducibility and repeatability of data obtained by oscillometry

A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors

Treatment options for hypertension in high-risk patients

Cardiovascular risk evaluation and prevalence of silent myocardial ischemia in subjects with asymptomatic carotid artery disease

Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study

Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies

Lipid-lowering therapy: who can benefit?

Hyperhomocysteinemia decreases bone blood flow

Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out

Decline of arterial cerebral infarction among young women: the Bergen Stroke Study

Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus

Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)

Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects

Extended-release ranolazine: critical evaluation of its use in stable angina

Signs for early diagnosis of heart failure in primary health care

Telmisartan and cardioprotection

Stiffness of the large arteries in individuals with and without Down syndrome

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ

Year: 2010, Volume: 7

Year: 2010, Volume: 6

Year: 2009, Volume: 5

Year: 2008, Volume: 4

Year: 2007, Volume: 3

Year: 2006, Volume: 2

Year: 2005, Volume: 1

Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program

Content Provider	PubMed Central
Author	Abraham, Ivo Macdonald, Karen Hermans, Christine Aerts, Ann Lee, Christopher Heidi, Brié Vancayzeele, Stefaan
Abstract	The pharmacological efficacy of various monotherapy, single pill, and combination therapies of the angiotensin II receptor blocker valsartan have been established, mainly through randomized controlled trials that used similar methodological and statistical platforms and thus enabled synthesis of evidence. The real world effectiveness of valsartan has been studied extensively, but the relative lack of scientific and technical congruence of these studies render synthesis virtually impossible. To date, all have focused on blood pressure outcomes, despite evidence-based calls to grade antihypertensive treatment to patients’ total cardiovascular risk. We review a T3 translational research program of seven studies involving valsartan monotherapy as well as single and separate pill combinations, and the determinants and effect on blood pressure and total cardiovascular risk outcomes. All seven studies examined not only the impact of valsartan-based regimens on blood pressure values and control, but also, within a statistical hierarchical approach, the physician- and patient-related determinants of these blood pressure outcomes. Two studies also investigated the determinants and outcomes of valsartan-based treatment on total cardiovascular risk – among the first studies to use this risk coefficient as an outcome rather than only a determinant. These seven studies included a total of 19,533 patients, contributed by 3434 physician-investigators in Belgium – a country particularly well-suited for observational effectiveness studies because of demographics and epidemiology. Each study used the same methodological and statistical platform. We summarize the impact of various valsartan regimens on such outcomes as blood pressure values and control, change in total cardiovascular risk, and reduction in risk by at least one category. We also review the results of statistical multilevel and logistic modeling of physician- and patient-related determinants on these outcomes, including the proportion of variance attributable to a physician class effect before patients enter the equation. In its different formulations, valsartan has major real-world benefits in lowering blood pressure and total cardiovascular risk within a 90-day period. It is essential to understand the physician- and patient-related determinants of blood pressure and total cardiovascular risk outcomes associated with valsartan treatment. Antihypertensive research should expand its historical focus on lowering blood pressure with an emphasis on lowering total cardiovascular research.
Related Links	http://dx.doi.org/10.2147/vhrm.s9434
Ending Page	235
Starting Page	209
File Format	PDF
ISSN	11782048
e-ISSN	11782048
Journal	Vascular Health and Risk Management
Volume Number	7
Language	English
Publisher	Dove Medical Press
Publisher Date	2011-03-01
Access Restriction	Open
Rights Holder	Dove Medical Press
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article

Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302

See location in the Map
03222 282435
Mail: support@ndl.gov.in

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in